XML 89 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
Financial Instruments
12 Months Ended
Dec. 31, 2015
Fair Value Disclosures [Abstract]  
Financial Instruments

8. Financial Instruments

We consider the recorded value of our certain financial assets and liabilities, which consist primarily of cash equivalents, accounts receivable, long-term receivables and accounts payable, to approximate the fair value of the respective assets and liabilities at December 31, 2015 and 2014, based on the short-term nature of the assets and liabilities. We determine the fair value of our long-term debt primarily based on quoted market prices for our 6% Senior Notes Due 2022 (the “2022 Notes”) at December 31, 2015. The fair value of our borrowings on our senior secured bank revolving credit facility (“Senior Bank Credit Facility”) approximates the carrying amount.  During the quarter ended September 30, 2015, we repurchased a portion of our 6 ¾% Senior Notes Due 2020 (the “2020 Notes”)  through a cash tender offer and satisfied and discharged the entire remaining amount of our 2020 Notes.  The fair value of our long-term debt is classified within Level 2 of the fair value hierarchy, because it is traded in less active markets.

The following table presents the carrying amounts and estimated fair values of our other financial instruments at December 31, 2015 and 2014:

 

 

 

December 31,

 

 

 

2015

 

 

2014

 

 

 

Carrying

 

 

Estimated

 

 

Carrying

 

 

Estimated

 

 

 

Amount

 

 

Fair Value

 

 

Amount

 

 

Fair Value

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition-related contingent consideration, including

   current portion (1)

 

$

4,394

 

 

$

4,394

 

 

$

6,338

 

 

$

6,338

 

Long-term debt, including current portion

 

 

500,000

 

 

 

513,500

 

 

 

711,000

 

 

 

735,000

 

Total

 

$

504,394

 

 

$

517,894

 

 

$

717,338

 

 

$

741,338

 

 

(1)

The short-term portion is included in “Accounts payable, accrued expenses and other.” The long-term portion is included in “Other liabilities.”

For business combinations consummated on or after January 1, 2009, we estimate the fair value of acquisition-related contingent consideration using a probability-weighted discounted cash flow model. This fair value measure is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Fair value measurements characterized within Level 3 of the fair value hierarchy are measured based on unobservable inputs that are supported by little or no market activity and reflect our own assumptions in measuring fair value.

The significant unobservable inputs used in the fair value measurements of our acquisition-related contingent consideration are our measures of the future profitability and related cash flows and discount rates. Significant increases (decreases) in any of these inputs in isolation would result in a significantly lower (higher) fair value measurement. Generally, a change in the assumptions used for the discount rates is accompanied by a directionally opposite change in the fair value measurement and a change in the assumptions used for the future cash flows is accompanied by a directionally similar change in the fair value measurement. The fair value of the contingent consideration is reassessed at each reporting period by the Company based on additional information as it becomes available. Any change in the fair value adjustment is recorded in the earnings of that period and is included within the “Acquisition-related contingent considerations” line in the Consolidated Statements of Comprehensive Income (Loss).  

During the years ended December 31, 2015, 2014, and 2013, management determined that the fair value of certain contingent consideration liabilities had declined. This remeasurement of the contingent consideration was based on management’s probability-adjusted present value of the consideration expected to be transferred during the remainder of the earnout period, based on the acquired operations’ forecasted results. The resulting reduction in the liability was recorded as income totaling $1.9 million, $2.7 million and $13.6 million for the years ended December 31, 2015, 2014 and 2013, respectively.

Accretion expense for acquisition-related contingent consideration totaled $0.7 million, $1.0 million and $2.7 million for years ended December 31, 2015, 2014 and 2013, respectively, and is included within “Acquisition-related contingent consideration” in the Consolidated Statements of Comprehensive Income (Loss).